Myogenica Inc.
Publicly observedSaint Paul, United States
Seen in a public record (e.g. a government grant database); not otherwise verified.
Details and provenance
| Item | Value | Source | Status |
|---|---|---|---|
| Country | US | NIH RePORTER (opens in a new tab) 28 Sept 2026 | Publicly observed |
| City / locality | Saint Paul | NIH RePORTER (opens in a new tab) 28 Sept 2026 | Publicly observed |
| Name | Myogenica Inc. | NIH RePORTER (opens in a new tab) 28 Sept 2026 | Publicly observed |
| UEI (U.S. federal entity ID) | LH5TFUV5JJ39 | NIH RePORTER (opens in a new tab) 28 Sept 2026 | Publicly observed |
Recorded events
- Grant25 Sept 2023Publicly observed
NIH SBIR/STTR award: Systemic Transplantation of MyoPAXon: IND Enabling Studies for the Treatment of DMD
USD 701,471.00 · National Institute of Arthritis and Musculoskeletal and Skin Diseases · Source: NIH RePORTER (opens in a new tab)
- Grant25 Sept 2023Publicly observed
NIH SBIR/STTR award: Systemic Transplantation of MyoPAXon: IND Enabling Studies for the Treatment of DMD
USD 1,266,814.00 · National Institute of Arthritis and Musculoskeletal and Skin Diseases · Source: NIH RePORTER (opens in a new tab)
Information only — not investment advice or an endorsement. Is this your company? Submit or update its details or request a correction.